Drug information provided by: Merative, Micromedex®
Enfortumab vedotin-ejfv injection is used to treat urothelial cancer (bladder cancer) that has spread or cannot be removed by surgery. It is used alone in patients who have tried other cancer medicines (eg, immunotherapy medicine, platinum-containing cancer medicine) or in patients who are not able to receive a cancer medicine that contains cisplatin and have received one or more prior treatments. It is also used in combination with pembrolizumab in patients who are not able to receive a cancer medicine that contains cisplatin.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2023
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Our $100,000 challenge is underway. Give now through Nov. 28th to double your impact on the future of healthcare.